Vanguard Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.98M Sell
2,416,909
-251,216
-9% -$413K ﹤0.01% 3291
2025
Q1
$4.86M Sell
2,668,125
-23,310
-0.9% -$42.4K ﹤0.01% 3182
2024
Q4
$9.99M Buy
2,691,435
+22,620
+0.8% +$83.9K ﹤0.01% 2959
2024
Q3
$8.54M Buy
2,668,815
+256,266
+11% +$820K ﹤0.01% 3036
2024
Q2
$19.8M Buy
2,412,549
+200,954
+9% +$1.65M ﹤0.01% 2573
2024
Q1
$32M Buy
2,211,595
+57,805
+3% +$838K ﹤0.01% 2363
2023
Q4
$19.8M Buy
2,153,790
+142,085
+7% +$1.31M ﹤0.01% 2600
2023
Q3
$33.2M Buy
2,011,705
+231,303
+13% +$3.82M ﹤0.01% 2328
2023
Q2
$11.3M Buy
1,780,402
+1,900
+0.1% +$12K ﹤0.01% 2872
2023
Q1
$6.04M Sell
1,778,502
-614,255
-26% -$2.09M ﹤0.01% 3215
2022
Q4
$13.8M Sell
2,392,757
-619,655
-21% -$3.58M ﹤0.01% 2815
2022
Q3
$28.3M Buy
3,012,412
+53,565
+2% +$504K ﹤0.01% 2472
2022
Q2
$66M Buy
2,958,847
+30,412
+1% +$678K ﹤0.01% 2061
2022
Q1
$161M Buy
2,928,435
+23,393
+0.8% +$1.29M ﹤0.01% 1680
2021
Q4
$192M Buy
2,905,042
+20,232
+0.7% +$1.34M ﹤0.01% 1634
2021
Q3
$242M Buy
2,884,810
+23,253
+0.8% +$1.95M 0.01% 1486
2021
Q2
$363M Buy
2,861,557
+127,044
+5% +$16.1M 0.01% 1211
2021
Q1
$300M Buy
2,734,513
+897,770
+49% +$98.5M 0.01% 1310
2020
Q4
$262M Buy
1,836,743
+504,805
+38% +$72.1M 0.01% 1301
2020
Q3
$94M Buy
1,331,938
+48,504
+4% +$3.42M ﹤0.01% 1714
2020
Q2
$89.8M Buy
1,283,434
+212,351
+20% +$14.9M ﹤0.01% 1731
2020
Q1
$37.4M Buy
1,071,083
+28,284
+3% +$989K ﹤0.01% 1994
2019
Q4
$65.6M Buy
1,042,799
+79,332
+8% +$4.99M ﹤0.01% 1966
2019
Q3
$32.3M Buy
963,467
+208,335
+28% +$6.98M ﹤0.01% 2268
2019
Q2
$19.6M Buy
755,132
+238,211
+46% +$6.19M ﹤0.01% 2520
2019
Q1
$8.55M Buy
516,921
+19,343
+4% +$320K ﹤0.01% 2910
2018
Q4
$5.39M Buy
497,578
+92,376
+23% +$1M ﹤0.01% 3059
2018
Q3
$10.1M Buy
405,202
+138,224
+52% +$3.46M ﹤0.01% 2911
2018
Q2
$5.81M Buy
266,978
+83,343
+45% +$1.81M ﹤0.01% 3158
2018
Q1
$2.69M Buy
+183,635
New +$2.69M ﹤0.01% 3359